Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-02-09 @ 1:41 AM
Study NCT ID:
NCT00532818
Status:
UNKNOWN
Last Update Posted:
2009-03-30
First Post:
2007-09-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hydralazine Valproate for Cervical Cancer
Sponsor:
National Institute of Cancerología
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2010-12
Completion Date Type:
ESTIMATED
First Submit Date:
2007-09-18
First Submit QC Date:
None
Study First Post Date:
2007-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-03-27
Last Update Post Date:
2009-03-30
Last Update Post Date Type:
ESTIMATED